U.S. flag

An official website of the United States government

NM_004183.4(BEST1):c.887A>G (p.Asn296Ser) AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Nov 1, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000086182.5

Allele description [Variation Report for NM_004183.4(BEST1):c.887A>G (p.Asn296Ser)]

NM_004183.4(BEST1):c.887A>G (p.Asn296Ser)

Gene:
BEST1:bestrophin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q12.3
Genomic location:
Preferred name:
NM_004183.4(BEST1):c.887A>G (p.Asn296Ser)
HGVS:
  • NC_000011.10:g.61959517A>G
  • NG_009033.1:g.14634A>G
  • NM_001139443.2:c.707A>G
  • NM_001300786.2:c.688-375A>G
  • NM_001300787.2:c.707A>G
  • NM_001363591.2:c.569A>G
  • NM_001363592.1:c.1090A>G
  • NM_001363593.2:c.-86A>G
  • NM_004183.4:c.887A>GMANE SELECT
  • NP_001132915.1:p.Asn236Ser
  • NP_001287716.1:p.Asn236Ser
  • NP_001350520.1:p.Asn190Ser
  • NP_001350521.1:p.Thr364Ala
  • NP_004174.1:p.Asn296Ser
  • NC_000011.9:g.61726989A>G
  • NM_004183.3:c.887A>G
  • NR_134580.2:n.1203A>G
  • O76090:p.Asn296Ser
Protein change:
N190S
Links:
UniProtKB: O76090#VAR_010484; dbSNP: rs281865255
NCBI 1000 Genomes Browser:
rs281865255
Molecular consequence:
  • NM_001363593.2:c.-86A>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001300786.2:c.688-375A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001139443.2:c.707A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001300787.2:c.707A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001363591.2:c.569A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001363592.1:c.1090A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004183.4:c.887A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NR_134580.2:n.1203A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000118326Retina International
no classification provided
not providednot providednot provided

SCV002228465Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 1, 2022)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Description

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providednot providednot providednot providednot providednot provided1not providedliterature only

Citations

PubMed

Allelic variation in the VMD2 gene in best disease and age-related macular degeneration.

Lotery AJ, Munier FL, Fishman GA, Weleber RG, Jacobson SG, Affatigato LM, Nichols BE, Schorderet DF, Sheffield VC, Stone EM.

Invest Ophthalmol Vis Sci. 2000 May;41(6):1291-6.

PubMed [citation]
PMID:
10798642

Identification of novel VMD2 gene mutations in patients with best vitelliform macular dystrophy.

Marchant D, Gogat K, Boutboul S, PĂ©quignot M, Sternberg C, Dureau P, Roche O, Uteza Y, Hache JC, Puech B, Puech V, Dumur V, Mouillon M, Munier FL, Schorderet DF, Marsac C, Dufier JL, Abitbol M.

Hum Mutat. 2001 Mar;17(3):235.

PubMed [citation]
PMID:
11241846
See all PubMed Citations (4)

Details of each submission

From Retina International, SCV000118326.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providednot providednot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1not providednot provided1not providednot providednot providednot providednot providednot provided

From Invitae, SCV002228465.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Asn296 amino acid residue in BEST1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10798642; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BEST1 protein function. ClinVar contains an entry for this variant (Variation ID: 99764). This missense change has been observed in individuals with autosomal dominant Best vitelliform macular dystrophy (PMID: 11241846, 27031371). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 296 of the BEST1 protein (p.Asn296Ser).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 16, 2024